C07J 41/0066
The 17-beta position being substituted by a carbon atom forming part of
Official title: {the 17-beta position being substituted by a carbon atom forming part of an amide group}
C07J41/0066 (The 17-beta position being substituted by a carbon atom forming part of) appears on 63 US grants and 45 published applications in this corpus.
Search patents in C07J- Granted patents
- 63
- Published applications
- 45
- Assignees
- 35
- Inventors
- 133
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 2 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 4 |
| 2017 | 2 | 4 |
| 2018 | 0 | 1 |
| 2019 | 3 | 4 |
| 2020 | 3 | 4 |
| 2021 | 2 | 6 |
| 2022 | 4 | 5 |
| 2023 | 4 | 4 |
| 2024 | 1 | 6 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- C17, C20, and C21 substituted neuroactive steroids and their methods of use16 Jun 2026US 12,655,175 B2Sage Therapeutics, Inc.
- Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof22 Apr 2025US 12,281,140 B2Enanta Pharmaceuticals, Inc.
- Compositions and methods for treating CNS disorders20 Aug 2024US 12,065,463 B2Sage Therapeutics, Inc.
- Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof8 Aug 2023US 11,718,641 B2Enanta Pharmaceuticals, Inc.
- Steroid derivative regulators, method for preparing the same, and uses thereof30 May 2023US 11,661,437 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Prodrugs for delivery of testosterone to the central nervous system15 Jan 2026US 2026/0014170 A1
- Prodrugs of Neurosteroid Analogs and Uses Thereof30 Jan 2025US 2025/0034200 A1Emory University
- Prodrugs of Neurosteroid Analogs and Uses Thereof23 Jan 2025US 2025/0026781 A1Emory University
- Stereoselective steroidal reductions26 Dec 2024US 2024/0425544 A1Sandhill One, LLC
- Novel compound that inhibits tnf-alpha generation and inflammasome activity and preparation method therefor28 Nov 2024US 2024/0391948 A1Seoul National University R&Db Foundation
Most cited
By later US patents
- 4-Aza-17.beta.-substituted-5.alpha.-androstan-3-one-reductase inhibitors159US 4,377,584 AMerck & Co., Inc. · 1983
- Preparation of 4-aza-17-substituted-5.alpha.-androstan-3-ones useful as 5.alpha.-reductase inhibitors68US 4,220,775 AMerck & Co., Inc. · 1980
- Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments59US 5,512,558 AHoechst Aktiengesellschaft · 1996
- Amphipathic, micellar delivery systems for biologically active polyions57US 5,635,487 A1997
- 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof46US 9,725,481 B2Sage Therapeutics, Inc. · 2017